WEBINAR ENDED
WEBINAR DETAILS
  • About
    The management will cover recent news related to the pipeline program.

    FluoGuide has decided to expand the design of the phase IIb trial in aggressive brain cancer with 24 patients instead of 12.

    Furthermore, FluoGuide has decided to explore FG001 in phase IIa clinical trials in three other severe cancer indications.
  • Agenda
    • Presentation by FluoGuide's management team
    • Q&A
  • Duration
    1 hour
  • Price
    Free
  • Language
    English
  • OPEN TO
    Anyone with the event link can attend
  • Dial-in Number
    Please register for this Webinar to view the dial-in info.
FEATURED PRESENTERS
  • Webinar hosting presenter

    Morten Albrechtsen

    CEO of FluoGuide
    Morten Albrechtsen is an MD and BBA (‘HD’ in marketing, CBS). Morten is a seasoned entrepreneur with a strong medical, commercial and financial background. The expertise is gained within a broad range of therapeutic areas and with both drugs and...
    Full Profile
  • Webinar hosting presenter

    Andreas Kjær

    CMO of FluoGuide
    Andreas Kjaer, is an MD, PhD, DMSc and professor at the University of Copenhagen and chief physician at Rigshospitalet, the National University Hospital of Denmark. His research is focused on molecular imaging with PET and PET/MRI in cancer and...
    Full Profile
  • 1612344010-9f7e3677cadaffde

    Henrik Moltke

    CFO of FluoGuide
    Henrik Moltke holds an MSc (Econ) in strategy and international economics and has more than 30 years of experience from life sciences and health care sectors, with roles such as CFO and Senior Vice President. The primary focus of his career has...
    Full Profile
HOSTED BY
ATTENDED (19)
Powered by BigMarker